Proteomics identifies differentially expressed proteins in glioblastoma U87 cells treated with hederagenin
Abstract Objective We investigated differentially expressed proteins (DEPs) in human glioblastoma U87 cells after treatment with hederagenin as a therapeutic screening mechanism and provided a theoretical basis for hederagenin in treating glioblastoma. Methods The Cell Counting Kit 8 assay was used...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | Proteome Science |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12953-023-00208-7 |